➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Moodys
Mallinckrodt
Merck
Colorcon

Last Updated: April 12, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ELOCON

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for ELOCON

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00763529 Elocon vs Fluticasone in Localized Psoriasis (P03197)(COMPLETED) Completed Schering-Plough Phase 4 2003-01-01 This is an open-label, randomized, parallel-group clinical study. The primary objective is to assess the difference in response rate between mometasone furoate cream 0.1% (once daily) vs fluticasone propionate cream 0.05% (twice daily) by the end of Day 4 and Day 8 in the management of Indian patients with localized psoriasis.
NCT01108198 Treatment of Phimosis With Topical Steroid Cream -Double-blind, Randomized, Placebo-controlled Study Unknown status University of Oulu Phase 4 2006-10-01 During last years topical steroid creams have been suggested to be effective treatment for non-retractable foreskin instead of circumcision. Aim of this study is to investigate the efficacy, safety and persistence of treatment results of a medium potent steroid cream in a double-blind, randomized, placebo-controlled study.
NCT02973776 Vasoconstriction Trial With LEO 90100 Aerosol Foam Recruiting LEO Pharma Phase 1 2016-12-01 Vasoconstriction study with LEO 90100
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for ELOCON

Condition Name

Condition Name for ELOCON
Intervention Trials
Psoriasis 1
Phimosis 1
Psoriasis Vulgaris 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for ELOCON
Intervention Trials
Psoriasis 2
Phimosis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for ELOCON

Trials by Country

Trials by Country for ELOCON
Location Trials
France 1
Finland 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for ELOCON

Clinical Trial Phase

Clinical Trial Phase for ELOCON
Clinical Trial Phase Trials
Phase 4 2
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for ELOCON
Clinical Trial Phase Trials
Completed 1
Recruiting 1
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ELOCON

Sponsor Name

Sponsor Name for ELOCON
Sponsor Trials
LEO Pharma 1
University of Oulu 1
Schering-Plough 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for ELOCON
Sponsor Trials
Industry 2
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Mallinckrodt
McKesson
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.